Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Chemcrux Enterprises Limited engages in the manufacture and sale of intermediates and chemicals in India. Its chemicals and intermediates products are used in the manufacture of bulk drugs active pharmaceutical ingredients, electro-plating, pharmaceuticals, dyes, and pigments. The company offers chloro benzoic, nitro benzoic acid, nitro salicylic, dichloro benzoic acid, chloro nitro benzoic acid, lasamide, arabonic acid sodium salt, chloro benzoic acid sulfonamide, BPEA sulfonamide, para and ortho chloro benzoyl chloride, and chloro benzoyl chloride. It serves multinationals and pharmaceutical organizations. The company also exports its products. Chemcrux Enterprises Limited was founded in 1983 and is based in Vadodara, India.
Key Metrics
as of Sep 2026
Market Cap 122 Cr
P/E 29.30
Div Yield 1.22 %
Book Value βΉ51.90
52w High βΉ159.00
52w Low βΉ64.00
Face Value βΉ10.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
21.94
24.28
23.00
18.55
16.75
15.97
19.42
17.76
17.11
18.54
21.81
15.84
22.29
Expenses
19.11
20.66
19.64
16.88
15.16
14.03
16.73
15.40
15.05
15.92
17.43
13.50
18.43
Operating Profit
2.83
3.62
3.36
1.67
1.59
1.94
2.69
2.36
2.06
2.62
4.38
2.34
3.86
OPM %
12.90
14.91
14.61
9.00
9.49
12.15
13.85
13.29
12.04
14.13
20.08
14.77
17.32
Other Income
0.31
0.53
0.74
0.80
0.61
0.28
0.61
0.26
0.39
0.35
0.56
0.24
0.18
Depreciation
0.95
0.94
0.95
0.96
0.95
0.91
0.92
0.73
0.56
0.55
0.58
0.58
0.57
Interest
0.34
0.40
0.46
0.52
0.52
0.58
0.60
0.33
0.13
0.13
0.17
0.21
0.31
Profit before tax
1.85
2.81
2.69
0.99
0.73
0.73
1.78
1.56
1.76
2.29
4.19
1.79
3.16
Tax %
25.95
29.18
22.68
18.18
19.18
35.62
25.84
26.28
29.55
3.49
36.75
30.17
26.27
Net Profit
1.37
1.99
2.08
0.80
0.58
0.47
1.33
1.15
1.24
2.21
2.66
1.24
2.33
EPS in Rs
0.93
1.34
1.40
0.54
0.39
0.32
0.90
0.78
0.84
1.49
1.80
0.84
1.57
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
82.58 70.25 78.47 95.15 95.27 53.33 57.45 55.27 31.45 27.43 20.09 19.60
Expenses
72.32 61.18 65.10 73.69 74.56 40.77 42.67 41.09 26.72 23.98 16.94 17.39
Operating Profit
10.26 9.07 13.37 21.46 20.71 12.56 14.78 14.18 4.73 3.45 3.15 2.21
OPM %
12.42 12.91 17.04 22.55 21.74 23.55 25.73 25.66 15.04 12.58 15.68 11.28
Other Income
2.67 1.53 1.18 1.05 1.00 0.84 0.90 -0.30 0.29 0.31 0.07 0.06
Interest
1.91 1.64 0.83 0.82 0.17 0.15 0.32 0.28 0.31 0.35 0.26 0.42
Depreciation
3.81 3.13 2.29 2.04 1.59 1.20 1.18 1.26 0.67 0.55 0.50 0.55
Profit before tax
7.21 5.83 11.43 19.65 19.95 12.05 14.18 12.34 4.04 2.86 2.46 1.30
Tax %
24.41 28.13 26.16 26.92 25.51 25.81 24.96 24.55 41.58 47.55 29.27 34.62
Net Profit
5.45 4.19 8.44 14.36 14.86 8.93 10.64 9.32 2.36 1.50 1.74 0.85
EPS in Rs
3.68 2.83 5.70 9.70 10.03 6.03 7.19 6.30 1.59 1.01 3.22 1.57
Dividend Payout %
27.17 35.35 17.55 20.63 19.93 11.06 18.57 2.65 5.23 8.23 2.59 5.29
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
14.81 14.81 14.81 14.81 14.81 4.94 4.94 4.94 4.94 4.94 1.80 1.80
Reserves
65.25 61.30 57.45 51.60 39.87 35.92 27.48 18.92 9.75 7.54 6.77 4.76
Borrowings
22.21 26.81 26.46 14.43 9.11 0.93 1.92 2.94 3.73 4.00 3.61 2.69
Other Liabilities
15.42 9.23 11.15 12.38 19.32 6.90 10.20 11.81 8.37 4.11 2.96 4.62
Total Liabilities
117.69 112.15 109.87 93.22 83.11 48.69 44.54 38.61 26.79 20.59 15.14 13.87
Fixed Assets
56.18 57.55 33.09 33.11 24.32 19.37 15.40 11.24 10.75 8.29 7.54 7.07
CWIP
4.08 1.61 21.06 0.31 0.00 0.32 0.00 0.00 0.00 0.21 0.00 0.00
Investments
15.94 19.84 19.83 16.79 7.09 9.35 6.53 3.89 1.07 0.05 0.05 0.05
Other Assets
41.49 33.15 35.89 43.01 51.70 19.65 22.61 23.48 14.97 12.04 7.55 6.75
Total Assets
117.69 112.15 109.87 93.22 83.11 48.69 44.54 38.61 26.79 20.59 15.14 13.87
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
12.20 7.07 16.34 14.82 9.14 9.62 10.90 8.05 3.50 1.41 0.83 1.52
Cash from Investing Activity
-2.28 -7.93 -25.89 -20.48 -2.64 -8.16 -7.62 -5.18 -4.17 -1.45 -0.97 -0.72
Cash from Financing Activity
-8.50 -3.18 7.64 0.96 2.76 -0.76 -3.56 -1.23 -0.07 1.94 -0.07 -0.29
Net Cash Flow
1.42 -4.04 -1.91 -4.70 9.26 0.69 -0.29 1.64 -0.74 1.90 -0.22 0.51
Free Cash Flow
7.29 -1.01 -6.85 3.71 4.57 3.46 5.53 5.56 0.36 -0.04 -0.14 0.82
CFO/OP %
132.00 94.00 142.00 86.00 69.00 100.00 98.00 84.00 87.00 72.00 42.00 76.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
85.08 63.44 71.17 51.56 72.33 22.65 59.79 71.52 74.28 56.69 65.22 42.46
Inventory Days
60.23 127.16 99.63 124.92 92.33 137.46 84.82 71.92 111.70 105.14 74.71 104.29
Days Payable
89.00 52.84 70.84 71.19 92.57 15.85 46.42 75.76 131.52 54.75 38.26 73.69
Cash Conversion Cycle
56.32 137.76 99.96 105.28 72.09 144.26 98.19 67.67 54.46 107.07 101.68 73.06
Working Capital Days
30.85 50.09 55.49 67.28 37.51 67.69 52.48 47.68 43.17 34.20 21.80 8.94
ROCE %
7.81 7.11 13.46 27.75 37.64 31.55 46.03 58.78 24.81 22.26 25.85 18.58
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
72.92
72.92
72.92
72.92
72.92
72.92
72.92
72.92
72.92
72.92
72.92
72.92
Public
27.08
27.09
27.08
27.07
27.07
27.07
27.07
27.07
27.08
27.09
27.06
27.07
No. of Shareholders
21,351
21,727
22,593
23,478
24,353
25,250
26,219
27,365
28,977
30,946
32,159
32,559
Corporate Actions
11 records
Back to all stocks